Original AOD 9604 5mg by Dragon Pharma
Product Overview
AOD 9604 5 mg is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (hGH). It is specifically engineered to promote fat metabolism without the anabolic or growth-related effects of full-length growth hormone.
Manufactured by Dragon Pharma, AOD-9604 is widely studied for its role in lipolysis (fat breakdown) and anti-obesity applications.
Drug Class
AOD-9604 belongs to the class of lipolytic peptides and growth hormone fragments, targeting fat metabolism pathways.
Indications
Primary Uses (Research Context)
- Fat loss and obesity research
- Body composition optimization
- Reduction of adipose tissue
Secondary Uses
- Metabolic enhancement
- Weight management support
- Improved lipid metabolism
Mechanism of Action
AOD-9604 works by mimicking the fat-reducing segment of growth hormone:
- Stimulates lipolysis (fat breakdown)
- Inhibits lipogenesis (fat storage)
- Activates pathways involved in fatty acid oxidation
- Does not significantly affect blood glucose or IGF-1 levels
Dosage & Administration
- Typical research dosing: 200–500 mcg daily
- Administered via subcutaneous injection
- Often taken in the morning or before fasted cardio
Note: Not approved for general medical use; protocols vary in research settings.
Pharmacokinetics
- Short half-life
- Rapid absorption via subcutaneous route
- Targeted action on adipose tissue metabolism
Effects & Benefits
- Targeted fat reduction
- No water retention
- No significant hormonal suppression
- Supports lean body composition
Synergy & Stacking
AOD-9604 is commonly combined with other compounds to enhance fat loss outcomes:
Combining with diet and exercise significantly enhances effectiveness.
Use in Females
AOD-9604 is considered safe for female use in research contexts due to its non-androgenic and non-hormonal nature.
Pre-Use Assessment
- Body composition evaluation
- Metabolic health assessment
- Review of current supplements or compounds
Effectiveness
Studies suggest AOD-9604 can promote fat loss, particularly when combined with caloric control and physical activity. Results are gradual and consistent.
Risk Management
Common Observations
- Mild injection site irritation
- Temporary fatigue
Serious Risks
- Limited long-term human data
- Unknown effects with prolonged use
Mitigation Strategies
- Use within controlled protocols
- Maintain proper hydration
- Monitor response closely
What to Avoid While Using AOD-9604
- High-calorie diets (counteracts fat loss)
- Combining with unverified substances
- Inconsistent dosing protocols
Drug Interactions
- Limited data available
- Caution with other metabolic agents
Conclusion
AOD 9604 5 mg is a targeted fat-loss peptide designed to enhance lipolysis without hormonal disruption. Its specificity and favorable profile make it a promising option in metabolic and body composition research.
What is the two peptide rule?
It refers to limiting peptide combinations to reduce complexity and potential side effects, often used in experimental protocols.
Where is the best place to inject peptides?
Common sites include the abdomen, thigh, or upper arm for subcutaneous injections.
How to decide what peptide to take?
Choice depends on goals such as fat loss, recovery, or performance, and should be guided by research or professional advice.
What time of day to inject peptides?
Timing depends on the peptide; AOD-9604 is often administered in the morning or before fasted activity.
